Richard Stead, consultant ophthalmologist and Newmedica glaucoma lead, shares insights for optometrists on drop-free cataract ...

Credit: Getty Images. OCS-01 is a novel, high concentration (15mg/mL), topical formulation of dexamethasone. Once-daily administration of an investigational corticosteroid eye drop (OCS-01) was found ...

WASHINGTON, Sept. 14, 2022 /PRNewswire/ -- The US Patent Office has issued Patent 11,439,590 to Scott Karolchyk (NDS) and Jeffrey Liegner MD (ECNW) for the legacy formulation of ophthalmic ...

A new report suggests corticosteroids likely are not a panacea for ocular surface disease, a potential adverse effect of trabeculectomy. Patients who took steroid eye drops before trabeculectomy for ...

Development plan positions OcuRing™-K for advancement in the fast-growing, multi-billion-dollar global cataract surgery ...

Children with uveitis appeared to have an increased risk of developing cataracts over 20-year follow-up, according to a retrospective cohort study. Among over 45,000 children, uveitis was associated ...